TMEM106B variants are known risk modifiers for FTD [129,130,185,186], while a single TMEM106B mutation is responsible for five unrelated cases of hypomyelinating leukodystrophy [143,187]. This evidence concerns the gene TMEM106B and leukodystrophy.